ALIGN TECHNOLOGY INC (ALGN) Form 8-K — Oct 28, 2026
$ALGNForm 8-KItems 5.02, 7.01, 9.01Filed Oct 28, 2026, 4:02 PM ET0001097149-26-000078Original filing
Align Technology announced a CEO succession plan on October 28, 2026: Jennifer L. Davis, former CEO of Procter & Gamble's Global Healthcare business, becomes CEO-elect and director on November 2, 2026, and President and CEO on December 31, 2026. She succeeds Joseph M. Hogan, who has led Align since 2015 and will retire as CEO on December 31, 2026, remain on the Board until June 2027, and serve as a strategic advisor under a one-year, $150,000 consulting agreement.
Key figures
- Ceo base salary
- 1300000
- Msu award value
- 9900000
- Rsu award value
- 6600000
- Doctor customers
- over 307 thousand
- Ceo signing bonus
- 2000000
- 2027 equity target
- 12000000
- Board size expansion
- 10 to 11 directors effective November 2, 2026
- Ceo target bonus pct
- 150%
- Severance multiple coc
- 2.5x salary + 2.5x target bonus
- Severance multiple non coc
- 2x salary + 2x target bonus
- Startup equity award value
- 16500000
- Hogan consulting fee annual
- 150000
- Patients treated cumulative
- approximately 24.2 million
- Relocation reimbursement cap
- 1000000
AI analysis
Red flags3 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.